Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Immunoglobulins Industry?
The market for immunoglobulins has seen robust growth in recent times. The market value is anticipated to increase from $18.85 billion in 2024 to $20.32 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.8%. Factors such as the rising numbers of immunodeficiency disorders, an expanding elderly population, increased usage of immunoglobulins in hospital settings, beneficial government reimbursement schemes, and an escalating prevalence of chronic and autoimmune diseases have all contributed to the growth during the historical period.
The market for immunoglobulins is forecasted to experience a significant increase in the coming years, with its size projected to reach “$30.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.0%. The growth predicted for this period can be associated with the rising investment in the development of advanced technologies, heightened understanding and awareness of immunodeficiency therapies, growing preference among medical professionals for these therapies, the rise of emerging markets, and the widening of its application in sports and fitness. Major emerging trends expected in this period include the advancement of wearable and smart compression devices, personalization of compression therapy solutions, incorporation of compression therapy in wound management, focus on patient comfort and compliance during compression therapy, and partnerships between manufacturers and health service providers for enhanced patient outcomes.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp
What Forces Are Driving The Growth Of The Immunoglobulins Industry?
The immunoglobulins market’s growth is being propelled by the rise in the elderly population. Seniors have a higher likelihood of contracting infectious and auto-immune diseases. Immunoglobulin tests reveal the capacity of one’s immune system to create antibodies that defend against bacteria, viruses, and allergies. For instance, a 2022 report from the World Health Organization (WHO), which oversees global public health from their base in Switzerland, projected that by 2030, one in six people globally will be 60 or older. By 2050, the global population of individuals aged 60 or older is anticipated to reach 2.1 billion. Therefore, the rise in the number of elderly individuals is predicted to spur demand in the immunoglobulins market over the forecast period.
What Is The Overview Of Market Segmentation In The Immunoglobulins Industry?
The immunoglobulins market covered in this report is segmented –
1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications
Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD
What Long-Term Trends Are Likely To Affect The Immunoglobulins Market?
Leading companies in the immunoglobulins market are creating groundbreaking products like intravenous immunoglobulins for greater customer reach, increased sales and higher revenue. In September 2024, for example, GC Biopharma, a biotech company based in South Korea, introduced ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, aiming to treat the primary humoral immunodeficiency (PI) in adults aged 17 years and older. Their offer now reaches the patients through speciality pharmacies. It’s a meaningful step as the U.S. is the largest immunoglobulin market in the world, estimated at about $11.6 billion. GC Biopharma has set a target of $50 million in ALYGLO sales in its debut year, with an objective to raise this amount to $300 million by 2028. This aggressive growth plan includes alliances with large U.S. pharmacy benefit managers and specialised pharmacies that are essential for effective distribution of immunoglobulin goods.
Who Are The Primary Players Operating Across The Global Immunoglobulins Market?
Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Which Region Offers The Most Growth Potential For The Immunoglobulins Market Through 2029?
North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
